Ember Therapeutics Inc (EMBT)
0.0001
0.00 (0.00%)
USD |
OTCM |
May 16, 16:00
Ember Therapeutics Cash from Operations (Quarterly): -0.006M for Sept. 30, 2015
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2015 | -0.006M |
| June 30, 2015 | -0.0015M |
| March 31, 2015 | -0.0043M |
| December 31, 2014 | -0.0031M |
| September 30, 2014 | -0.0026M |
| June 30, 2014 | -0.0099M |
| Date | Value |
|---|---|
| March 31, 2014 | -0.0011M |
| December 31, 2013 | -0.0068M |
| September 30, 2013 | -0.0138M |
| June 30, 2013 | -0.0002M |
| March 31, 2013 | -0.0018M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Nutranomics Inc | -0.0328M |
| EVIO Inc | -0.0597M |
| Ubiquitech Software Corp | -0.0848M |
| M2Bio Sciences Inc | -- |
| Verde Science Inc | -- |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | 0.0055M |